How I Use Measurable Residual Disease in the Clinical Management of Adult Acute Lymphoblastic Leukemia

Over the last decade the use of measurable residual disease (MRD) diagnostics in adult acute lymphoblastic leukemia (ALL) has expanded from a limited number of study groups in Europe and the United States to a world-wide application. In this review, we summarize the advantages and drawbacks of the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, Fiona, Robertson, Harry Frederick, El-Zahab, Sarah, Pavlů, Jiří
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690704/
https://www.ncbi.nlm.nih.gov/pubmed/34938985
http://dx.doi.org/10.2991/chi.k.211119.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690704/
https://www.ncbi.nlm.nih.gov/pubmed/34938985
http://dx.doi.org/10.2991/chi.k.211119.001

Ejemplares similares